41 related articles for article (PubMed ID: 8985519)
1. Hyperthermic isolated limb perfusion increases circulating levels of inflammatory cytokines.
Quinn TD; Polk HC; Edwards MJ
Cancer Immunol Immunother; 1995 Apr; 40(4):272-75. PubMed ID: 7750126
[TBL] [Abstract][Full Text] [Related]
2. Generation and Functional
Kurena B; Müller E; Christopoulos PF; Johnsen IB; Stankovic B; Øynebråten I; Corthay A; Zajakina A
Front Immunol; 2017; 8():1667. PubMed ID: 29276511
[TBL] [Abstract][Full Text] [Related]
3. TNF-alpha and melphalan-based isolated limb perfusion: no evidence supporting the early destruction of tumour vasculature.
Podleska LE; Funk K; Umutlu L; Grabellus F; Taeger G; de Groot H
Br J Cancer; 2015 Aug; 113(4):645-52. PubMed ID: 26171939
[TBL] [Abstract][Full Text] [Related]
4. The pathologic response of resected synovial sarcomas to hyperthermic isolated limb perfusion with melphalan and TNF-α: a comparison with the whole group of resected soft tissue sarcomas.
Schwindenhammer B; Podleska LE; Kutritz A; Bauer S; Sheu SY; Taeger G; Schmid KW; Grabellus F
World J Surg Oncol; 2013 Aug; 11(1):185. PubMed ID: 23938063
[TBL] [Abstract][Full Text] [Related]
5. The antibody-based targeted delivery of TNF in combination with doxorubicin eradicates sarcomas in mice and confers protective immunity.
Hemmerle T; Probst P; Giovannoni L; Green AJ; Meyer T; Neri D
Br J Cancer; 2013 Sep; 109(5):1206-13. PubMed ID: 23887603
[TBL] [Abstract][Full Text] [Related]
6. Long-term locoregional vascular morbidity after isolated limb perfusion and external-beam radiotherapy for soft tissue sarcoma of the extremity.
Hoven-Gondrie ML; Thijssens KM; Van den Dungen JJ; Loonstra J; van Ginkel RJ; Hoekstra HJ
Ann Surg Oncol; 2007 Jul; 14(7):2105-12. PubMed ID: 17457649
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-alpha damages tumor blood vessel integrity by targeting VE-cadherin.
Menon C; Ghartey A; Canter R; Feldman M; Fraker DL
Ann Surg; 2006 Nov; 244(5):781-91. PubMed ID: 17060772
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1beta induced vascular permeability is dependent on induction of endothelial tissue factor (TF) activity.
Puhlmann M; Weinreich DM; Farma JM; Carroll NM; Turner EM; Alexander HR
J Transl Med; 2005 Sep; 3():37. PubMed ID: 16197553
[TBL] [Abstract][Full Text] [Related]
9. Treatment of patients with unresectable primary hepatic malignancies using hyperthermic isolated hepatic perfusion.
Feldman ED; Wu PC; Beresneva T; Helsabeck C; Rodriguez M; Bartlett DL; Libutti SK; Pingpank JF; Alexander HR
J Gastrointest Surg; 2004 Feb; 8(2):200-7. PubMed ID: 15036196
[TBL] [Abstract][Full Text] [Related]
10. Dynamic contrast-enhanced MR imaging in monitoring response to isolated limb perfusion in high-grade soft tissue sarcoma: initial results.
van Rijswijk CS; Geirnaerdt MJ; Hogendoorn PC; Peterse JL; van Coevorden F; Taminiau AH; Tollenaar RA; Kroon BB; Bloem JL
Eur Radiol; 2003 Aug; 13(8):1849-58. PubMed ID: 12942285
[TBL] [Abstract][Full Text] [Related]
11. Degree of tumour vascularity correlates with drug accumulation and tumour response upon TNF-alpha-based isolated hepatic perfusion.
van Etten B; de Vries MR; van IJken MG; Lans TE; Guetens G; Ambagtsheer G; van Tiel ST; de Boeck G; de Bruijn EA; Eggermont AM; ten Hagen TL
Br J Cancer; 2003 Jan; 88(2):314-9. PubMed ID: 12610519
[TBL] [Abstract][Full Text] [Related]
12. TNF-alpha augments intratumoural concentrations of doxorubicin in TNF-alpha-based isolated limb perfusion in rat sarcoma models and enhances anti-tumour effects.
van der Veen AH; de Wilt JH; Eggermont AM; van Tiel ST; Seynhaeve AL; ten Hagen TL
Br J Cancer; 2000 Feb; 82(4):973-80. PubMed ID: 10732774
[TBL] [Abstract][Full Text] [Related]
13. Feasibility and efficacy of external beam radiotherapy after hyperthermic isolated limb perfusion with TNF-alpha and melphalan for limb-saving treatment in locally advanced extremity soft-tissue sarcoma.
Olieman AF; Pras E; van Ginkel RJ; Molenaar WM; Schraffordt Koops H; Hoekstra HJ
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):807-14. PubMed ID: 9531364
[TBL] [Abstract][Full Text] [Related]
14. FDG-PET to evaluate response to hyperthermic isolated limb perfusion for locally advanced soft-tissue sarcoma.
van Ginkel RJ; Hoekstra HJ; Pruim J; Nieweg OE; Molenaar WM; Paans AM; Willemsen AT; Vaalburg W; Koops HS
J Nucl Med; 1996 Jun; 37(6):984-90. PubMed ID: 8683328
[TBL] [Abstract][Full Text] [Related]
15. Hyperthermic isolated limb perfusion with tumour necrosis factor-alpha and melphalan as palliative limb-saving treatment in patients with locally advanced soft-tissue sarcomas of the extremities with regional or distant metastases. Is it worthwhile?
Olieman AF; van Ginkel RJ; Molenaar WM; Schraffordt Koops H; Hoekstra HJ
Arch Orthop Trauma Surg; 1998; 118(1-2):70-4. PubMed ID: 9833110
[TBL] [Abstract][Full Text] [Related]
16. Hyperthermic isolated limb perfusion for the treatment of soft tissue sarcomas.
Schraffordt Koops H; Eggermont AM; Liénard D; Kroon BB; Hoekstra HJ; Van Geel AN; Nieweg OE; Lejeune FJ
Semin Surg Oncol; 1998; 14(3):210-4. PubMed ID: 9548603
[TBL] [Abstract][Full Text] [Related]
17. Hyperthermic isolated limb perfusion with tumour necrosis factor and melphalan as treatment of locally advanced or recurrent soft tissue sarcomas of the extremities.
Schraffordt Koops H; Eggermont AM; Liènard D; Kroon BB; Hoekstra HJ; van Geel AN; Nieweg OE; Lejeune FJ
Radiother Oncol; 1998 Jul; 48(1):1-4. PubMed ID: 9756165
[TBL] [Abstract][Full Text] [Related]
18. Angiographic response of locally advanced soft-tissue sarcoma following hyperthermic isolated limb perfusion with tumor necrosis factor.
Olieman AF; van Ginkel RJ; Hoekstra HJ; Mooyaart EL; Molenaar WM; Koops HS
Ann Surg Oncol; 1997 Jan; 4(1):64-9. PubMed ID: 8985519
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
